Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
J Immunol ; 190(7): 3764-71, 2013 Apr 01.
Article in English | MEDLINE | ID: mdl-23440413

ABSTRACT

The contribution of natural CD4(+)CD25(+) regulatory T cells (nTregs) in controlling graft rejection and the mechanism used remain controversial. Using the duality of the 2.102 TCR Ag recognition, we were able to study, for the first time to our knowledge, the involvement of nTregs in the two pathways of allorecognition in a murine adoptive transfer model in which TCR-transgenic nTregs were or were not depleted before transplantation. We show that nTregs used at a physiological ratio were able to delay graft rejection after direct alloreactivity by controlling proliferation and differentiation of alloreactive CD4(+) conventional T cells in draining lymph nodes. In contrast, similar results were found in the indirect alloreactivity pathway only when nTregs were used in high numbers. In the latter pathway, nTregs used at a physiological ratio failed to delay graft rejection and to control proliferation of conventional T cells. These results support recent therapeutic approaches aimed at producing and using in vitro Ag-specific Foxp3(+) nTregs to control graft rejection in transplantation. Finally, late inhibition of Th1 differentiation was shown in indirect alloreactivity, but this suppression could also be mediated by Foxp3(+)-induced Tregs.


Subject(s)
Isoantigens/immunology , T-Lymphocytes, Regulatory/immunology , Animals , CD4 Antigens/metabolism , Cell Differentiation/immunology , Cell Proliferation , Graft Rejection/immunology , Immunophenotyping , Interleukin-2 Receptor alpha Subunit/metabolism , Lymph Nodes/immunology , Lymph Nodes/metabolism , Male , Mice , Mice, Knockout , Phenotype , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , T-Lymphocytes, Regulatory/metabolism , Th1 Cells/cytology , Th1 Cells/immunology
2.
J Immunol ; 186(11): 6271-9, 2011 Jun 01.
Article in English | MEDLINE | ID: mdl-21518974

ABSTRACT

Neutralization of macrophage migration inhibitory factor (MIF) increases anti-tumor cytotoxic T cell responses in vivo and IFN-γ responses in vitro, suggesting a plausible regulatory role for MIF in T cell activation. Considering that IFN-γ production by CD4(+) T cells is pivotal to resolve murine malaria and that secretion of MIF is induced by Plasmodium chabaudi adami parasites, we investigated the effect of MIF deficiency on the infection with this pathogen. Infections with P. c. adami 556 KA parasites were more efficiently controlled in MIF-neutralized and MIF-deficient (knockout [KO]) BALB/c mice. The reduction in parasitemia was associated with reduced production of IL-4 by non-T/non-B cells throughout patent infection. At day 4 postinfection, higher numbers of activated CD4(+) cells were measured in MIF KO mice, which secreted more IFN-γ, less IL-4, and less IL-10 than did CD4(+) T cells from wild-type mice. Enhanced IFN-γ and decreased IL-4 responses also were measured in MIF KO CD4(+) T cells stimulated with or without IL-12 and anti-IL-4 blocking Ab to induce Th1 polarization. However, MIF KO CD4(+) T cells efficiently acquired a Th2 phenotype when stimulated in the presence of IL-4 and anti-IL-12 Ab, indicating normal responsiveness to IL-4/STAT6 signaling. These results suggest that by promoting IL-4 responses in cells other than T/B cells during early P. c. adami infection, MIF decreases IFN-γ secretion in CD4(+) T cells and, additionally, has the intrinsic ability to render CD4(+) T cells less capable of acquiring a robust Th1 phenotype when stimulated in the presence of IL-12.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Macrophage Migration-Inhibitory Factors/immunology , Malaria/immunology , Plasmodium chabaudi/immunology , Animals , Antibodies/immunology , Antibodies/pharmacology , Blotting, Western , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/metabolism , Cell Proliferation , Down-Regulation , Female , Flow Cytometry , Host-Parasite Interactions/immunology , Interferon-gamma/immunology , Interferon-gamma/metabolism , Interleukin-10/immunology , Interleukin-10/metabolism , Interleukin-12/pharmacology , Interleukin-4/immunology , Interleukin-4/metabolism , Macrophage Migration-Inhibitory Factors/genetics , Macrophage Migration-Inhibitory Factors/metabolism , Malaria/genetics , Malaria/parasitology , Male , Mice , Mice, Inbred BALB C , Mice, Knockout , Parasitemia/immunology , Parasitemia/metabolism , Parasitemia/prevention & control , Plasmodium chabaudi/physiology , Th1 Cells/drug effects , Th1 Cells/immunology , Th1 Cells/metabolism , Time Factors , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism
3.
In. Apollon, Willy. Tratar la psicosis. Buenos Aires, Polemos, 1997. p.156-160. (92936).
Monography in Spanish | BINACIS | ID: bin-92936
4.
In. Apollon, Willy. Tratar la psicosis. Buenos Aires, Polemos, 1997. p.158-160. (92935).
Monography in Spanish | BINACIS | ID: bin-92935
5.
In. Apollon, Willy. Tratar la psicosis. Buenos Aires, Polemos, 1997. p.151-158. (92934).
Monography in Spanish | BINACIS | ID: bin-92934
SELECTION OF CITATIONS
SEARCH DETAIL
...